TALIS BIOMEDICAL CORP (TLIS)

US87424L2079 - Common Stock

9.03  -0.17 (-1.85%)

Buy % Consensus

37

ChartMill assigns a Buy % Consensus number of 37% to TLIS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.1. This target is -43.52% below the current price.
TLIS was analyzed by 6 analysts. The buy percentage consensus is at 37. So analysts seem to be rather negative about TLIS.
In the previous month the buy percentage consensus was at a similar level.
TLIS was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 9.035.055.105.105.25 - -44.08% -43.52% -43.52% -41.86%

Related screens

Up and Down Grades
Date Firm Action Rating
2023-08-16 BTIG Maintains Sell -> Sell
2022-01-07 B of A Securities Downgrade Neutral -> Underperform
2021-09-27 JP Morgan Downgrade Neutral -> Underweight
2021-08-12 Piper Sandler Downgrade Overweight -> Neutral
2021-08-11 JP Morgan Downgrade Overweight -> Neutral
2021-03-09 BTIG Initiate Buy
2021-03-09 JP Morgan Initiate Overweight
2021-03-09 B of A Securities Initiate Neutral
2021-03-09 Piper Sandler Initiate Overweight